Association of serum levels of vascular endothelial growth factor and thrombospondin-1 to body mass index in polycystic ovary syndrome: a case-control study

키워드

참고문헌 (33)

1. Qu J, "The higher response of vascular endothelial growth factor and angiotensin-ii to human chorionic gonadotropin in women with polycystic ovary syndrome", Int J Fertil Steril, 8, pp.373~378 (2015)
2. Peitsidis P, "Role of vascular endothelial growth factor in women with PCO and PCOS : a systematic review", Reprod Biomed Online, 20, pp.444~452 (2010)
3. Diamanti-Kandarakis E, "Role of obesity and adiposity in polycystic ovary syndrome", Int J Obes, 31(Suppl 2), pp.S8~S13 (2007)
4. Jin CH, "Body fat distribution and its associated factors in Korean women with polycystic ovary syndrome", J Obstet Gynaecol Res, 41, pp.1577~1583 (2015)
5. El Hayek S, "Poly cystic ovarian syndrome : an updated overview", Front Physiol, 7, pp.124~ (2016)
6. Wang R, "The Rotterdam criteria for polycystic ovary syndrome : evidence-based criteria", Hum Reprod, 32, pp.261~264 (2017)
7. Bani Mohammad M, "Polycystic ovary syndrome(PCOS), diagnostic criteria, and AMH", Asian Pac J Cancer Prev, 18, pp.17~21 (2017)
8. Osz K, "The thrombospondin-1 receptor CD36 is an important mediator of ovarian angiogenesis and folliculogenesis", Reprod Biol Endocrinol, 12, pp.21~ (2014)
9. Geva E, "Role of vascular endothelial growth factor in ovarian physiology and pathology", Fertil Steril, 74, pp.429~438 (2000)
10. Holmes DI, "The vascular endothelial growth factor(VEGF)family : angiogenic factors in health and disease", Genome Biol, 6, pp.209~ (2005)
11. Greenaway J, "Vascular endothelial growth factor and its receptor, Flk-1", KDR, are cytoprotective in the extravascular compartment of the ovarian follicle, 2004, pp.145, 2896~2905
12. Ferrara N, "The role of VEGF in the regulation of physiological and pathological angiogenesis", EXS, (94), pp.209~231 (2005)
13. Loebig M, "Evidence for a relationship between VEGF and BMI independent of insulin sensitivity by glucose clamp procedure in a homogenous group healthy young men", PLoS One, 5, pp.e12610~ (2010)
14. Lawler J, "Tumor progression : the effects of thrombospondin-1 and-2", Int J Biochem Cell Biol, 36, pp.1038~1045 (2004)
15. Varma V, "Thrombospondin-1 is an adipokine associated with obesity, adipose inflammation, and insulin resistance", Diabetes, 57, pp.432~439 (2008)
16. Tan BK, "Metformin decreases angiogenesis via NF-kappaB and Erk1", 2, Cardiovasc Res, pp.2009, 83[DOI]
17. Maxel T, "Expression patterns and correlations with metabolic markers of zinc transporters ZIP14 and ZNT1 in obesity and polycystic ovary syndrome", Front Endocrinol(Lausanne), 8, pp.38~ (2017)
18. Sanchez N, "A life course perspective on polycystic ovary syndrome", Int J Womens Health, 6, pp.115~122 (2014)
19. F. BCJM, "Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome: Rotterdam ESHRE", ASRM-Sponsored 3rd PCOS Consensus Workshop Group, 2004, pp.81, 19~25
20. Souza Dos Santos AC, "The impact of body mass on inflammatory markers and insulin resistance in polycystic ovary syndrome", Gynecol Endocrinol, 31, pp.225~228 (2015)
21. Kahn HS, "The"lipid accumulation product"performs better than the body mass index for recognizing cardiovascular risk : a population-based comparison", BMC Cardiovasc Disord, 5, pp.26~ (2005)
22. Wiltgen D, "Lipid accumulation product index : a reliable marker of cardiovascular risk in polycystic ovary syndrome", Hum Reprod, 24, pp.1726~1731 (2009)
23. Duleba AJ, "Is PCOS an inflammatory process", Fertil Steril, 97, pp.7~12 (2012)
24. Harada M, "Expression of vascular endothelial growth factor A during ligand-induced down-regulation of luteinizing hormone receptor in the ovary", Mol Cell Endocrinol, 328, pp.28~33 (2010)
25. Bhattacharyya S, "Cell type-specific post-transcriptional regulation of production of the potent antiangiogenic and proatherogenic protein thrombospondin-1 by high glucose", J Biol Chem, 283, pp.5699~5707 (2008)
26. Tada H, "High glucose levels enhance TGF-beta1-thrombospondin-1 pathway in cultured human mesangial cells via mechanisms dependent on glucose-induced PKC activation", J Diabetes Complications, 15, pp.193~197 (2001)
27. Ebrahimi-Mamaghani M, "Association of insulin resistance with lipid profile, metabolic syndrome, and hormonal aberrations in overweight or obese women with polycystic ovary syndrome", J Health Popul Nutr, 33, pp.157~167 (2015)
28. Tahergorabi Z, "The relationship between inflammatory markers, angiogenesis, and obesity", ARYA Atheroscler, 9, pp.247~253 (2013)
29. Goossens GH, "Adipose tissue oxygen tension : implications for chronic metabolic and inflammatory diseases", Curr Opin Clin Nutr Metab Care, 15, pp.539~546 (2012)
30. Sun K, "Selective inhibition of hypoxia-inducible factor 1αameliorates adipose tissue dysfunction", Mol Cell Biol, 33, pp.904~917 (2013)
31. Elias I, "Adipose tissue overexpression of vascular endothelial growth factor protects against diet-induced obesity and insulin resistance", Diabetes, 61, pp.1801~1813 (2012)
32. Bråkenhielm E, "Adiponectin-induced antiangiogenesis and antitumor activity involve caspasemediated endothelial cell apoptosis", Proc Natl Acad Sci U S A, 101, pp.2476~2481 (2004)
33. Malavazos AE, "The"lipid accumulation product"is associated with 2-hour postload glucose outcomes in overweight", obese subjects with nondiabetic fasting glucose, 2015, pp.2015, 836941~

관련 논문AI추천